Oxycodone/Oxymorphone, Screen and Confirmation, Urine
Also known as: Numorphin®, Opana®, Oxycontin®
Use
Detect and confirm the presence of oxycodone or oxymorphone
Special Instructions
This assay is intended for pain management purposes and is not suitable for workplace drug testing. It does not meet the regulatory requirements for workplace testing programs in various states. Specimens should be maintained at room temperature and if the arrival at the laboratory is expected to be delayed beyond seven days, refrigeration is recommended.
Limitations
The assay is specifically designed to detect oxycodone and oxymorphone and may not detect other opioids or substances. It should not be used for legal purposes or employment-related drug testing due to its design for clinical contexts particularly in pain management. Results should be interpreted in the context of the patient's clinical condition and other diagnostic information.
Methodology
Immunoassay (Mass Spectrometry)
Biomarkers
LOINC Codes
- 58430-0
- 19643-6
- 16249-5
- 18325-1
- 17395-5
- 77202-0
Result Turnaround Time
3-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Plastic urine container
Storage Instructions
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.